Reply: High-dose oral glutamine can reduce cerebrospinal fluid glutamate in mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes without a beneficial clinical or cerebral tissue effect

EUROPEAN JOURNAL OF NEUROLOGY(2023)

引用 0|浏览0
暂无评分
摘要
European Journal of NeurologyVolume 30, Issue 4 p. 1158-1159 LETTER TO THE EDITOR Reply: High-dose oral glutamine can reduce cerebrospinal fluid glutamate in mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes without a beneficial clinical or cerebral tissue effect María Paz Guerrero-Molina, Corresponding Author María Paz Guerrero-Molina maripazguerrero@gmail.com orcid.org/0000-0001-5114-5689 Neuromuscular Disorders Unit, Neurology Department, October 12 University Hospital, Madrid, Spain Correspondence María Paz Guerrero-Molina, Neuromuscular Disorders Unit, Neurology Department, University Hospital, 12 de Octubre Madrid, Spain. Email: maripazguerrero@gmail.comSearch for more papers by this authorCristina Domínguez-González, Cristina Domínguez-González orcid.org/0000-0001-5151-988X Neuromuscular Disorders Unit, Neurology Department, October 12 University Hospital, Madrid, Spain Spanish Network for Biomedical Research in Rare Diseases (CIBERER), Madrid, Spain Research Institute (imas12), October 12 University Hospital, Madrid, SpainSearch for more papers by this authorJesús González de la Aleja, Jesús González de la Aleja orcid.org/0000-0001-8197-1519 Epilepsy Unit, Neurology Department, October 12 University Hospital, Madrid, SpainSearch for more papers by this author María Paz Guerrero-Molina, Corresponding Author María Paz Guerrero-Molina maripazguerrero@gmail.com orcid.org/0000-0001-5114-5689 Neuromuscular Disorders Unit, Neurology Department, October 12 University Hospital, Madrid, Spain Correspondence María Paz Guerrero-Molina, Neuromuscular Disorders Unit, Neurology Department, University Hospital, 12 de Octubre Madrid, Spain. Email: maripazguerrero@gmail.comSearch for more papers by this authorCristina Domínguez-González, Cristina Domínguez-González orcid.org/0000-0001-5151-988X Neuromuscular Disorders Unit, Neurology Department, October 12 University Hospital, Madrid, Spain Spanish Network for Biomedical Research in Rare Diseases (CIBERER), Madrid, Spain Research Institute (imas12), October 12 University Hospital, Madrid, SpainSearch for more papers by this authorJesús González de la Aleja, Jesús González de la Aleja orcid.org/0000-0001-8197-1519 Epilepsy Unit, Neurology Department, October 12 University Hospital, Madrid, SpainSearch for more papers by this author First published: 16 January 2023 https://doi.org/10.1111/ene.15683Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article. Volume30, Issue4April 2023Pages 1158-1159 RelatedInformation
更多
查看译文
关键词
cerebrospinal fluid glutamate,mitochondrial encephalomyopathy,cerebral tissue effect,lactic acidosis
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要